Techniques in Assessing Fatigue in Neuromuscular Diseases

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 1, 2012, Pages 11-22

  Lou, Jau Shin ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fatigue; Fatigue questionnaires; Mental fatigability; Neuromuscular diseases; Physical fatigability; Subjective and physiologic fatigue

Indexed keywords

LEVODOPA;

CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSTHYMIA; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; EXERCISE TEST; FATIGUE SEVERITY SCALE; HUMAN; INSTRUMENT VALIDATION; LABORATORY TEST; MULTIDIMENSIONAL FATIGUE INVENTORY; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE TWITCH; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM FUNCTION; PIPER FATIGUE SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL ANALOG SCALE;

CENTRAL NERVOUS SYSTEM; EXERCISE TEST; FATIGUE; HUMANS; MENTAL FATIGUE; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; PERIPHERAL NERVOUS SYSTEM; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84855722554     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2011.11.003     Document Type: Review

References (44)

1. Angeard N., Gargiulo M., Jacquette A., et al. Cognitive profile in childhood myotonic dystrophy type 1: Is there a global impairment?. Neuromuscul Disord 2007, 17:451-458.
2. Fauci A.S., Braunwald E., Kasper D.L., et al. Harrison's principles of internal medicine 2008, McGraw-Hill Medical, New York. 17th edition.
3. Lou J.S., Kearns G., Oken B., et al. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 2001, 16:190-196.
4. Krupp L.B., Avarez L.A., Larocca N.G., et al. Fatigue in multiple sclerosis. Arch Neurol 1988, 45:435-437.
5. Krupp L.B., LaRocca N.G., Muir-Nash J., et al. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123.
6. Smets E.M., Grassen B., Bonke B., et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. JPsychosom Res 1995, 39:315-325.
7. Piper P.F., Dibble S.L., Dodd M.J., et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998, 25:677-684.
8. Lou J.S., Reeves A., Benice T., et al. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003, 60:122-123.
9. Strohschein F.J., Kelly C.G., Clarke A.G., et al. Applicability, validity, and reliability of the Piper Fatigue Scale in postpolio patients. Am J Phys Med Rehabil 2003, 82:122-129.
10. Brunier G., Graydon J. Acomparison of two methods of measuring fatigue in patients on chronic haemodialysis: visual analogue vs Likert scale. Int J Nurs Stud 1996, 33:338-348.
11. Meek P.M., Nail L.M., Barsevick A., et al. Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 2000, 49:181-190.
12. Smets E.M., Garssen B., Schuster-Uitterhoeve A.L., et al. Fatigue in cancer patients. Br J Cancer 1993, 68:220-224.
13. Schneider R.A. Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs 1998, 21:370-373.
14. Breslin E., van der Schans C., Breukink S., et al. Perception of fatigue and quality of life in patients with COPD. Chest 1998, 114:958-964.
15. Breukink S.O., Strijbos J.H., Koorn M., et al. Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease. Respir Med 1998, 92:676-682.
16. Piper P.F., Lindsey A.M., Dodd M.J., et al. The development of an instrument to measure the subjective dimension of fatigue. Key aspects of comfort: management of pain, fatigue, and nausea 1989, 199-208. Springer, New York. S.G. Funk, E.M. Tornquist, M.T. Champagne (Eds.).
17. Dean G.E., Spears L., Ferrell B.R., et al. Fatigue in patients with cancer receiving interferon alpha. Cancer Pract 1995, 3:164-172.
18. Varvaro F.F., Sereika S.M., Zullo T.G., et al. Fatigue in women with myocardial infarction. Health Care Women Int 1996, 17:593-602.
19. Grady C., Anderson R., Chase G.A. Fatigue in HIV-infected men receiving investigational interleukin-2. Nurs Res 1998, 47:227-234.
20. Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. JPsychosom Res 1993, 37:147-153.
21. Boentert M., Dziewas R., Heidbreder A., et al. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. JNeurol 2010, 257:646-652.
22. Vollestad N.K. Measurement of human muscle fatigue. JNeurosci Methods 1997, 74:219-227.
23. Schillings M.L., Hoefsloot W., Stegeman D.F., et al. Relative contributions of central and peripheral factors to fatigue during a maximal sustained effort. Eur J Appl Physiol 2003, 90:562-568.
24. Samii A., Wassermann E.M., Ikoma K., et al. Characterization of postexercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation. Neurology 1996, 46:1376-1382.
25. Gandevia S.C., Allen G.M., Butler J.E., et al. Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. JPhysiol 1996, 490:529-536.
26. Gandevia S.C. Twitch interpolation: a valid measure with misinterpreted meaning. JAppl Physiol 2009, 107(1):363-364. [discussion: 367-8].
27. Schillings M.L., Kalkman J.S., Janssen H.M., et al. Experienced and physiological fatigue in neuromuscular diseases. Clin Neurophysiol 2007, 118:292-300.
28. Sharma K.R., Kent-Braun J.A., Majumdar S., et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 1995, 45:733-740.
29. Kent-Braun J., Miller R.G. Central fatigue during isometric exercise in amyotrophic lateral sclerosis. Muscle Nerve 2000, 23:909-914.
30. Oken B.S., Salinsky M.C., Elsas S.M. Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol 2006, 117(9):1885-1901.
31. Posner M.I., Petersen S.E. The attention system of the human brain. Annu Rev Neurosci 1990, 13:25-42.
32. Marrocco R.T., Davidson M.C. Neurochemistry of attention. The attentive brain 1998, 35-50. MIT, Cambridge (MA). R. Parasuraman (Ed.).
33. Corbetta M., Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 2002, 3(3):201-215.
34. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 2000, 31(2-3):251-269.
35. Fan J., McCandliss B.D., Sommer T., et al. Testing the efficiency and independence of attentional networks. JCogn Neurosci 2002, 14(3):340-347.
36. Mezzacappa E. Alerting, orienting, and executive attention: developmental and socio-demographic properties in an epidemiological sample of young, urban children. Child Dev 2004, 75(5):1373-1386.
37. Rueda R., Fan J., McCandliss B.D., et al. Development of attentional networks in childhood. Neuropsychologia 2004, 42(8):1029-1040.
38. Bish J.P., Ferrante S.M., McDonald-McGinn D., et al. Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11.2 deletion syndrome. Dev Sci 2005, 8(1):36-43.
39. Sobin C., Kiley-Brabeck K., Daniels, et al. Networks of attention in children with the 22q11 deletion syndrome. Dev Neuropsychol 2004, 26(2):611-626.
40. Mullane J.C., Corkum P.V., Klein R.M., et al. Alerting, orienting, and executive attention in children with ADHD. JAtten Disord 2011, 15(4):310-320.
41. Posner M.I., Rothbart M.K., Vizueta N., et al. Attentional mechanisms of borderline personality disorder. Proc Natl Acad Sci USA 2002, 99(25):16366-16370.
42. Wang K., Fan J., Dong Y., et al. Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophr Res 2005, 78(2-3):235-241.
43. Hendriksen J.G., Vles J.S. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. JChild Neurol 2008, 23(5):477-481.
44. Boosman H., Visser-Meily J.M., Meijer J.W., et al. Evaluation of change in fatigue, self-efficacy and health-related quality of life, after a group educational intervention programme for persons with neuromuscular diseases or multiple sclerosis: a pilot study. Disabil Rehabil 2011, 33(8):690-696.